Ewa Święszkowska

ORCID: 0000-0001-5167-9648
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Brain Metastases and Treatment
  • Radiation Therapy and Dosimetry
  • Childhood Cancer Survivors' Quality of Life
  • Testicular diseases and treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Ocular Oncology and Treatments
  • Sarcoma Diagnosis and Treatment
  • Vascular Malformations Diagnosis and Treatment
  • Hedgehog Signaling Pathway Studies
  • Anesthesia and Neurotoxicity Research
  • Fetal and Pediatric Neurological Disorders
  • Oral health in cancer treatment
  • Cerebrovascular and genetic disorders
  • Cerebral Venous Sinus Thrombosis
  • Organ Transplantation Techniques and Outcomes
  • ATP Synthase and ATPases Research
  • S100 Proteins and Annexins
  • Renal and related cancers
  • Family Support in Illness
  • Extracellular vesicles in disease
  • Advanced Glycation End Products research
  • Caveolin-1 and cellular processes

Children's Memorial Health Institute
2010-2024

Instytut Matki i Dziecka
2010

The aim of this study was to assess the long-term results liver transplantation (LT) in pediatric patients with unresectable hepatoblastoma (HB) or hepatocellular carcinoma (HCC) special reference risk tumor recurrence. We retrospectively analyzed data from 46 HB and 26 HCC who underwent LT between 1990 2022. In patients, we compared outcomes depending on donor type. evaluated impact a number factors recurrence-free survival after LT. Estimated patient 5, 10, 15 years 82%, 73%, 73% group...

10.3390/children11020193 article EN cc-by Children 2024-02-03

The aim of this study was to evaluate the health status children cured from hepatoblastoma. Forty-five patients with hepatoblastoma treated between 1996-2014 were assessed. recorded data included sex, age at diagnosis, disease stage, treatment methods, time since and evaluation domains which performance status, growth development, hearing, cardiovascular, skeletal, gastrointestinal, genitourinary, neurological, hematological function. There 30 boys 15 girls. diagnosis ranged one month 14...

10.3390/cancers11111777 article EN Cancers 2019-11-11

Abstract BACKGROUND Pediatric ependymomas are aggressive central nervous system malignancies arising from the ependymal linings of ventricles and spinal canal. Despite better understanding tumor biology remain therapeutic challenge in pediatric neurooncology. The role chemotherapy remains controversial. Herein, we describe outcomes patients treated at largest center Poland who underwent surgery, pre-irradiation irradiation regardless extent surgical resection. METHODS This retrospective...

10.1093/neuonc/noae064.215 article EN cc-by-nc Neuro-Oncology 2024-06-18

Abstract INTRODUCTION Infants constitute approximately 5% of all pediatric LGG. This group is identified as having aggressive course and worse prognosis compared to older children. No specific therapeutic guidelines are yet available for this age group. AIM: Retrospective analysis infants diagnosed treated METHODOLOGY: 25 patients between 2001-2023 were analyzed for: sex, age, tumor location, pathology, treatment outcome. NF1 excluded. RESULTS There 13 boys 12 girls, aged 3 months-11 months,...

10.1093/neuonc/noae064.420 article EN cc-by-nc Neuro-Oncology 2024-06-18

Rhabdomyosarcoma (RMS) of the biliary tract is a rare tumor in children, constituting 0.5–0.8% all pediatric RMS. Still, it most common malignancy this location children. Due to its rarity and location, may cause diagnostic treatment difficulties. Above all, there are no therapeutic guidelines specific for location. The aim study was present an analysis our experience with children rhabdomyosarcoma discuss clinical recommendations published literature. A retrospective medical records eight...

10.3390/cancers16173110 article EN Cancers 2024-09-09
Raju Antony M. Zagardo Meena Gujrati Julie Lin Raju Antony and 95 more Mohamad M. Al‐Rahawan M. Zagardo Meena Gujrati Julie Lin Alberto Broniscer Rakesh Bhardwaj Cliff Wayne Hampton V. Ozols M. Chakravadhanula Éric Bouffet C. Hawkins Katrin Scheinemann Shayna Zelcer D. Johnston Lucie Lafay‐Cousin Vincent Larouche Nada Jabado Anne Sophie Carret Juliette Hukin David D. Eisenstat Gregory R. Pond Kenneth J. Poskitt Blair Wilson U. Bartels Uri Tabori G.I. Dhall Kristina M. Haley Jane C Finlay Teresa Rushing Richard Sposto Robert C. Seeger John S. Garvin Khushbu Rupani Elizabeth Stark J. L. Ross Anderson Neil A. Feldstein J's Sports Bar and Grill Darren Hargrave Maura Massimino Tim Jaspan Pascale Varlet Charles H. Jones Patricia Morgan Marie‐Cécile Le Deley A. Azizi Adela Cañete Éric Bouffet Frank Saran Jeanette Bachir Lida Bubuteishvili‐Pacaud Romain Rousseau G. Vassal Sachin Gupta Nan Robinson N. Dhir Kristin Wong Shi Jie Zhou Jane C Finlay G.I. Dhall Toshihiro Kumabe Takashi Kawaguchi Ryo� Saito Mariano Kanamori Yushiro Yamashita Y. Sonoda Takehiro Tominaga Takuya Miyagawa Chisaraokwu Nwachukwu Ryan S. Youland Nadia N. Laack Iwona Filipek Monika Drogosiewicz M. P.- Polnik Ewa Święszkowska Bożenna Dembowska–Bagińska Elżbieta Jurkiewicz Danuta Perek Danuta Perek Bożenna Dembowska–Bagińska Monika Drogosiewicz M. P.- Polnik Wiesława Grajkowska Marcin Roszkowski Grażyna Sobol Katarzyna Musioł Jacek Wachowiak Barbara Kaźmierczak J Pogorzelski Wojciech Młynarski B. Z.- Szewczyk Mirosław J Wysocki Ewa Niedzielska Jerzy Kowalczyk H. W. - Slusarz Walentyna Balwierz

10.1093/neuonc/not185 article EN Neuro-Oncology 2013-11-01
Soumen Khatua Robert W. Brown Mark D. Pearlman Tribhawan S. Vats Daniel Satgé and 95 more C Stiller Stefan Rutkowski André O. von Bueren Bernard Lacour D Sommelet Masaharu Nishi Maura Massimino Maria Luisa Garrè Fernando Moreno Henrik Hasle Zsuzsanna Jakab Maurice Greenberg N. von der Weid Claudia E. Kuehni Óscar Zurriaga Mireia Vicente Rafael Peris‐Bonet Matthew G.K. Benesch Marcel Vekemans S Sullivan Christian Rickert Paul G. Fisher Julie Von Behren Debi Nelson Patricia M. Reynolds Kohei Fukuoka Tetsu Yanagisawa T Suzuki Tomohiro Koga Kenji Wakiya Jun Adachi Kōichi Mishima Takamitsu Fujimaki M Matsutani Ryutaro Nishikawa Corrie Gidding Jolanda Schieving Pieter Wesseling Marjolijn J. L. Ligtenberg Nicoline Hoogerbrugge Marjolijn C.J. Jongmans Stephen Crosier Sarah Leigh Nicholson K. Robson Thomas S. Jacques Stephen B. Wharton N Bown A. Michalski Barry Pizer Steven C. Clifford Emma Sandén E. Visse Peter Siesjö Anna Darabi Darryl Nousome Philip J. Lupo Michael E. Scheurer Irena Nulman María José Arias Barrera Christina R. Maxwell Gideon Koren S K Gorelyshev Kaspot Matuev A. Lubnin Michail S. Laskov N. Lemeneva Nadezhda Mazerkina E. Khuhlaeva Klaus Müller Florian Bruns Torsten Pietsch Stefan Rutkowski Rolf‐Dieter Kortmann Rahul Krishnatry Neelam Shirsat R. Kunder Sridhar Epari Tapas K. Das Gupta Purna Kurkure Tushar Vora B Arora Aliasgar Moiyadi Rakesh Jalali Ewa Święszkowska Bożenna Dembowska–Bagińska Monika Drogosiewicz Iwona Filipek Marta Perek‐Polnik Wiesława Grajkowska Danuta Perek David Johnston J. Cyr Douglas Strother Lucie Lafay‐Cousin Chris Fryer

BACKGROUND: Malignant pediatric brain tumors constitute a heterogeneic group of central nervous system tumors, and general markers diagnosis prognosis are not available. Recently, panel CD (CD15, CD24, CD29) was used to define increasing neural differentiation embryonic stem cells. Although these have been associated with worse due presence tumor propagating cells, alterations in adhesion migration various cancer types, no studies multiple performed. METHODS: We collected including...

10.1093/neuonc/nos100 article EN Neuro-Oncology 2012-06-01

LG-49. LOW GRADE GLIOMA (LGG) OF THE SPINAL CORD. SPECIFIC LOCATION NEEDS TREATMENT Marta Perek-Polnik, Iwona Filipek, Monika Drogosiewicz, Ewa Swieszkowska, Wieslawa Grajkowska, Elzbieta Jurkiewicz, Marcin Roszkowski, and Bozenna Dembowska-Baginska; The Children’s Memorial Health Institute, Warsaw, Poland INTRODUCTION: Spinal cord LGG constitute approximately 3,5% of all locations. No specific therapeutic guidelines are available for this site. AIM: Analysis childhood spinal LGG....

10.1093/neuonc/now075.49 article EN Neuro-Oncology 2016-06-01
Katie M. Strobel PJ SIMPSON Patricia A. Donohoue S. Firat Sachin Jogal and 95 more J.-S. Lai Jennifer L. Beaumont Stewart Goldman Chieh-Yin Huang Maru Barrera Alan Rokeach Kelly Hancock Danielle Cataudella Fiona Schulte Jun-Mo Chung Ute Bartels L. Janzen Lillian Sung Doug Strother J. Hukin Andrea Downie S. Zelcer Eshetu G. Atenafu Elisabetta Schiavello Veronica Biassoni Cristina Meazza Marta Podda Maura Massimino Elizabeth Wells Nicole J. Ullrich Kristy Seidel Wendy M. Leisenring Charles A. Sklar Gregory T. Armstrong Lisa Diller Allison A. King Kevin R. Krull Joseph P. Neglia Marilyn Stovall Kevin Whelan L. L. Robison Roger J. Packer Tiina Remes Arja Harila‐Saari Maria Suo‐Palosaari Päivi M. Lähteenmäki Pekka Arikoski Pekka Riikonen Heikki Rantala Marja Ojaniemi Kim Bull C.O. Kennedy Simon Bailey D. W. Ellison Steven C. Clifford Bożenna Dembowska–Bagińska Agnieszka Brożyna Monika Drogosiewicz Marta Perek‐Polnik Ewa Święszkowska Iwona Filipek Magdalena Tarasińska Justyna Korzeniewska Danuta Perek Duarte Salgado Sofía Nunes PL Pereira Sofia Vinhais S. Salih Sarah Z Elsarrag E Prange K. Contreas Peggy Possin Sharon Frierdich J. Eickhoff Diane Puccetti Chieh-Yin Huang Elena J. Ladas C. Buck N. Arbit Thora Gudrunardottir Birgitta Lannering Marc Remke Martin Taylor Elizabeth Wells Robert F. Keating Roger J. Packer Stacie Stapleton J. Flanary Frances Hamblin Ernest K. Amankwah Suzy Ghazarian Charissa T. Jagt Marianne D. van de Wetering Antoinette Y. N. Schouten–van Meeteren J.-S. Lai Cindy J. Nowinski William F. Hartsell J. H.-C. Chang David Cella

10.1093/neuonc/nou079 article EN Neuro-Oncology 2014-06-01

Craniospinal irradiation (CSI) has been a major component of the standard care treatment backbone for childhood medulloblastoma. However, chemotherapy regimens have varied based on protocol, patient age, and molecular subtyping. In one largest studies to date, we analyzed outcomes in children with newly-diagnosed medulloblastoma treated pre-irradiation followed by risk-adapted radiotherapy maintenance chemotherapy. A total 153 patients from Polish Pediatric Neuro-Oncology Group were included...

10.3390/children10081387 article EN cc-by Children 2023-08-15

Abstract Craniospinal irradiation (CSI) has been a major component of the standard care treatment backbone childhood medulloblastoma. However, chemotherapy regimens have varied based on protocol, patient age, and molecular subtyping. In one largest studies to date, we analyze outcomes in children with newly-diagnosed medulloblastoma treated pre-irradiation followed by risk-adapted radiotherapy maintenance chemotherapy. A total 153 patients from Polish Pediatric Neuro-oncology Group were...

10.1093/neuonc/noad179.0837 article EN Neuro-Oncology 2023-11-01

Pineoblastoma is a rare, highly aggressive supratentorial tumour, more frequently diagnosed in young children. The prognosis remains poor. AIM: To present own experience with children pineoblastoma. PATIENTS AND 14 pts: 8 girls and 6 boys treated between 1998 2017 were analyzed. 5 pts (36%) under 3 years of age. 7 underwent complete tumour resection, 2-partial resection 5- biopsy. At the onset treatment six patients had disseminated disease. 9 according to protocol for MB HR group (with...

10.1093/neuonc/noy059.043 article EN Neuro-Oncology 2018-06-01

Astroblastoma is a rare CNS tumor of glial origin distinguished from other gliomas in the recent International Classification Tumors Central Nervous System proposed by World Health Organization. We present our experience with 3 astroblastoma patients. Between 2003–2017 among 978 patients tumors treated at Institution (0,3 %) were diagnosed astroblastoma. There 2 girls and 1 boy aged 2.5, 3, 5.5 years. Two had supratentorial tumors, one was located infratentorially. All underwent subtotal...

10.1093/neuonc/noy059.051 article EN Neuro-Oncology 2018-06-01

The aim of the study was to asses QoL in Medulloblastoma (MB) survivors according risk groups. MATERIAL AND Between 2005-2015 132 patients (40 girls, 92 boys aged 2 9/12 – 17 6/12) were treated MB. 44 standard and 88 high risk. Patients SR group received radiotherapy CNS 25Gy whereas HR - 36Gy. Age at analysis 6 1/12 29. Analysis included 5 year EFS/OS assessment of: weight/height percentiles groups age diagnosis, hearing loss, aids, hair loss occurrence posterior fossa syndrome(PFS)....

10.1093/neuonc/noy059.613 article EN Neuro-Oncology 2018-06-01

Abstract BACKGROUND: The last two decades have witnessed several efforts to minimize the adverse sequelae of craniospinal irradiation (CSI), a standard care treatment modality in medulloblastoma. This has been accomplished by adding chemotherapy backbone. use pre-irradiation also previously reported. In one largest studies date, we analyze outcomes children with and high-risk medulloblastoma treated followed reduced-dose radiotherapy SR maintenance chemotherapy. METHODS: Data from Polish...

10.1093/neuonc/noac079.400 article EN cc-by-nc Neuro-Oncology 2022-06-01
Coming Soon ...